Skip to content

Building a platform for surveying and sharing information on patients with inflammatory bowel disease using social network services.

Building a platform for surveying and sharing information on patients with inflammatory bowel disease using social network services. - IBD-LINQ

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000047474
Enrollment
500
Registered
2022-05-01
Start date
2022-06-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease, Crohn&#39

Interventions

None listed

Sponsors

Tohoku University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diagnosis of inflammatory bowel disease (Crohn's disease, ulcerative colitis, intestinal Behcet's disease, etc.) The individual is using the LINE service operated by LINE Corporation on his/her mobile device.

Exclusion criteria

Exclusion criteria: (1) Those who have difficulty using the LINE service (2) Others whom the attending physician deems inappropriate

Design outcomes

Primary

MeasureTime frame
Annual change in response rate for regular survey questionnaires Response rates and trends for irregular surveys

Secondary

MeasureTime frame
Enrollment rate in the system among patients attending an outpatient clinic for the disease in question Differences in response rates between anonymized and linkable anonymized questionnaires Differences in response rates between surveys that generate rewards and those that do not Comparison of all of the above by disease, gender, and age group

Countries

Japan

Contacts

Public ContactYoichi Kakuta

Tohoku University Hospital Division of Gastroenterology

ykakuta@med.tohoku.ac.jp0227177171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026